Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY 4.0BMC Medicine

Treated and untreated maternal asthma and early pregnancy outcomes: a retrospective cohort study of 324,238 infants

Abstract

Background: Continued use of asthma medication during pregnancy is recommended, because asthma exacerbations often increase during pregnancy, and poor control may adversely affect maternal and foetal health. However, evidence on whether adverse outcomes arise from the treatment itself or just the underlying disease remains inconsistent. This study examined the relationship between maternal asthma, and its medication, and early pregnancy outcomes.

Methods: A retrospective birth cohort was constructed using population-wide linked Welsh health records of 324,238 infants born between 2009 and 2022. Logistic regression was used to investigate associations between maternal asthma (treated, untreated, and medication exposure) and pregnancy outcomes: stillbirth, iatrogenic and spontaneous preterm delivery, small/very small for gestational age (SGA/VSGA), and low Apgar score.

Results: Of the 324,238 infants, 39,040 (12.0%) had mothers with asthma: 20,840 (6.4%) had treated asthma, 8,230 (2.5%) had untreated asthma, and 9,970 (3.1%) were prescribed asthma medications without recorded asthma diagnoses. Compared to offspring of mothers with no maternal asthma (reference group), those whose mothers had treated asthma had higher odds of SGA (aOR 1.13, 95% CI 1.07–1.19), VSGA (aOR 1.14, 95% CI 1.03–1.26), Apgar score < 7 (aOR 1.14, 95% CI 1.01–1.29), and iatrogenic preterm delivery (aOR 1.13, 95% CI 1.01–1.26). Associations were observed across multiple classes of asthma medication with stronger associations among the offspring of mothers prescribed more than one medication class and those with add-on therapies including long-acting muscarinic antagonists, short-acting muscarinic antagonists, leukotrienes antagonist and theophylline, consistent with more severe, or poorly controlled, asthma rather than medication effects. Untreated asthma was associated with higher risk of iatrogenic preterm delivery, and treated asthma was associated with lower risk of spontaneous preterm delivery (aOR 0.81, 95% CI 0.73–0.89). No associations were observed with stillbirth.

Conclusions: The non-specific associations observed across different classes of asthma medication and dose-relationships with polytherapy suggested confounding by indication and severity. The findings for iatrogenic preterm delivery further supported an effect of the underlying disease rather than its treatment. These findings, together with the lower risk of spontaneous preterm delivery among treated mothers, support guideline recommendations to continue asthma treatment during pregnancy.

Related

  1. Treated and untreated maternal asthma and adverse pregnancy outcomes
    LA Shakhshir, JP Pell, CE Hastie +3
    The European Journal of Public HealthPeer-reviewedCC BY-NC 4.0Full textEpidemiology & public healthPMCEurope PMC
  2. Maternal Obesity and Outcomes During Pregnancy and the Puerperium: A Single-Center Retrospective Observational Study
    Denise Souza Ribeiro, Luiz Felipe Azevedo Marques, Fernando Augusto Lima Marson
    Medical sciences (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Uterine Fibroids in Pregnancy: Maternal, Obstetric, and Neonatal Outcomes in a Retrospective Cohort Study
    Francesco Giuseppe Martire, Claudia d’Abate, Eugenia Costantini +6
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Development and internal validation of prediction models for maternal adverse pregnancy outcomes in HELLP syndrome: a retrospective cohort study in China
    Yanfang Lu, Xiaoru Huang, Xiaosong Lin +2
    Frontiers in EndocrinologyPeer-reviewedCC BY 4.0Endocrinology & metabolismCrossref
  5. Association of third-trimester maternal lipid levels with adverse pregnancy outcomes in women with gestational diabetes mellitus: a retrospective single-center study using intrapartum data
    Yuqi Yang, Yue Peng, Jiuxiang Fan +3
    The Journal of Maternal-Fetal & Neonatal MedicinePeer-reviewedCC BYFull textObstetrics, gynaecology & paediatricsDOAJ
BibTeX
@article{shakhshir2026treated,
  title = {{Treated and untreated maternal asthma and early pregnancy outcomes: a retrospective cohort study of 324,238 infants}},
  author = {Lama A Shakhshir and Jill P Pell and Claire E Hastie and Scott M Nelson and Sarjit Singh and Michael Fleming},
  journal = {BMC Medicine},
  year = {2026},
  month = nov,
  doi = {10.1186/s12916-026-05391-w},
  url = {https://link.springer.com/article/10.1186/s12916-026-05391-w},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Treated and untreated maternal asthma and early pregnancy outcomes: a retrospective cohort study of 324,238 infants
AU  - Lama A Shakhshir
AU  - Jill P Pell
AU  - Claire E Hastie
AU  - Scott M Nelson
AU  - Sarjit Singh
AU  - Michael Fleming
PY  - 2026
DA  - 2026/11/16
JO  - BMC Medicine
DO  - 10.1186/s12916-026-05391-w
UR  - https://link.springer.com/article/10.1186/s12916-026-05391-w
AB  - Background: Continued use of asthma medication during pregnancy is recommended, because asthma exacerbations often increase during pregnancy, and poor control may adversely affect maternal and foetal health. However, evidence on whether adverse outcomes arise from the treatment itself or just the underlying disease remains inconsistent. This study examined the relationship between maternal asthma, and its medication, and early pregnancy outcomes.  Methods: A retrospective birth cohort was constructed using population-wide linked Welsh health records of 324,238 infants born between 2009 and 2022. Logistic regression was used to investigate associations between maternal asthma (treated, untreated, and medication exposure) and pregnancy outcomes: stillbirth, iatrogenic and spontaneous preterm delivery, small/very small for gestational age (SGA/VSGA), and low Apgar score.  Results: Of the 324,238 infants, 39,040 (12.0%) had mothers with asthma: 20,840 (6.4%) had treated asthma, 8,230 (2.5%) had untreated asthma, and 9,970 (3.1%) were prescribed asthma medications without recorded asthma diagnoses. Compared to offspring of mothers with no maternal asthma (reference group), those whose mothers had treated asthma had higher odds of SGA (aOR 1.13, 95% CI 1.07–1.19), VSGA (aOR 1.14, 95% CI 1.03–1.26), Apgar score < 7 (aOR 1.14, 95% CI 1.01–1.29), and iatrogenic preterm delivery (aOR 1.13, 95% CI 1.01–1.26). Associations were observed across multiple classes of asthma medication with stronger associations among the offspring of mothers prescribed more than one medication class and those with add-on therapies including long-acting muscarinic antagonists, short-acting muscarinic antagonists, leukotrienes antagonist and theophylline, consistent with more severe, or poorly controlled, asthma rather than medication effects. Untreated asthma was associated with higher risk of iatrogenic preterm delivery, and treated asthma was associated with lower risk of spontaneous preterm delivery (aOR 0.81, 95% CI 0.73–0.89). No associations were observed with stillbirth.  Conclusions: The non-specific associations observed across different classes of asthma medication and dose-relationships with polytherapy suggested confounding by indication and severity. The findings for iatrogenic preterm delivery further supported an effect of the underlying disease rather than its treatment. These findings, together with the lower risk of spontaneous preterm delivery among treated mothers, support guideline recommendations to continue asthma treatment during pregnancy.
SN  - 1741-7015
ER  -